Truong Vu 4
4 · Aridis Pharmaceuticals, Inc. · Filed Mar 13, 2019
Insider Transaction Report
Form 4
Truong Vu
DirectorCEO, CSO, Director10% Owner
Transactions
- Award
Stock Options
2019-02-20+200,000→ 316,861 totalExercise: $8.46Exp: 2029-02-20→ Common Stock (200,000 underlying)
Footnotes (1)
- [F1]The Stock Options vest in equal installments over 48 months, beginning on March 20, 2019.